The Evolving Economy

How COVID-19 might impact the longevity economy

Healthcare has come under the spotlight during the coronavirus pandemic, as the sector is seen as a key part of the solution to global health emergency. It is also a key part of the longevity investment theme, because on average as we age, we consume more healthcare goods and services.

Among the healthcare companies that have benefited from their part in dealing with the coronavirus pandemic are telehealth providers. This increased use of digital technology to provide healthcare services is reflecting a longer-term trend of how healthcare systems need to change, to deal with the fact that we have a large aging population globally. Even before the COVID-19 crisis, there were questions around how we manage that demand and build a more sustainable healthcare system for the long term.

Other parts of the longevity economy have not fared so well. Silver spending is an important aspect of the longevity economy and includes activities such as travel and leisure. The dramatic reduction in global travel as a consequence of the COVID-19 pandemic has been perhaps most visible in the cruise line industry, with the last major vessel now returned to port.

The key question is whether travellers believe going on a cruise is a safe activity after recent events. Previous crises faced by the cruise industry suggest demand will bounce back, but when and to what extent is unclear.

Financial planning is another important activity for the silver spender. If you want to unlock the benefits of a long life, you need to be thinking about how your money is going to last you perhaps over a longer period than you had earlier anticipated.

Private banks and wealth managers’ share prices declined during the stock market volatility in the first quarter of 2020. But taking a long-term view, it seems certain that financial planning will remain an essential activity to unlocking the full benefits of a longer life, so we are not overly concerned about recent short-term movements.

One underappreciated aspect of the crisis is the potential for increased demand for health and protection insurance from consumers in countries with underdeveloped healthcare systems - particularly those experiencing significant COVID-19 outbreaks. We have seen weak share price performance from multiple insurers operating in this space, but over the long term this crisis may stimulate greater demand for their products.

At the same time, it is important to consider longevity being about the whole of life rather than just the end of life. For example, you can’t reach your 80s and decide to start to run marathons and live to be 100 as a result – you probably need to be doing these things over your whole life.

Education also comes into the ‘whole of life’ approach to longevity. While many parents are currently home schooling their children, and perhaps appreciating in a new way the challenges of education, we have been considering this for some time. People who might live to 100 are not necessarily going to find that things they learnt at school are all still applicable 40 years further down the line. This creates opportunities for companies in the whole of life and ongoing education and training sector.

Despite the outbreak, global populations continue to age, and we expect global life expectancies to creep higher over the long term, therefore although we may see some changes in consumption patterns post-COVID-19, the key drivers of the longevity economy remain intact.

Not for Retail distribution: This document is intended exclusively for Professional, Institutional, Qualified or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.

This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.

Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

Issued in the UK by AXA Investment Managers UK Limited, which is authorised and regulated by the Financial Conduct Authority in the UK. Registered in England and Wales No: 01431068. Registered Office: 7 Newgate Street, London EC1A 7NX.

In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries.